Source: BMC Infectious Diseases. Unidade: FM
Subjects: HPV (DIAGNÓSTICO;EFEITOS;PREVALÊNCIA), DOENÇAS SEXUALMENTE TRANSMISSÍVEIS, TESTES SOROLÓGICOS, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO-SOUZA, Patricia S. de et al. Determinants of baseline seroreactivity to human papillomavirus type 16 in the Ludwig-McGill cohort study. BMC Infectious Diseases, v. 14, p. 578, 2014Tradução . . Disponível em: https://doi.org/10.1186/s12879-014-0578-0. Acesso em: 19 nov. 2024.APA
Araujo-Souza, P. S. de, Ramanakumar, A. V., Candeias, J. M. G., Thomann, P., Trevisan, A., Franco, E. L., & Villa, L. L. (2014). Determinants of baseline seroreactivity to human papillomavirus type 16 in the Ludwig-McGill cohort study. BMC Infectious Diseases, 14, 578. doi:10.1186/s12879-014-0578-0NLM
Araujo-Souza PS de, Ramanakumar AV, Candeias JMG, Thomann P, Trevisan A, Franco EL, Villa LL. Determinants of baseline seroreactivity to human papillomavirus type 16 in the Ludwig-McGill cohort study [Internet]. BMC Infectious Diseases. 2014 ; 14 578.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1186/s12879-014-0578-0Vancouver
Araujo-Souza PS de, Ramanakumar AV, Candeias JMG, Thomann P, Trevisan A, Franco EL, Villa LL. Determinants of baseline seroreactivity to human papillomavirus type 16 in the Ludwig-McGill cohort study [Internet]. BMC Infectious Diseases. 2014 ; 14 578.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1186/s12879-014-0578-0
